Holding(s) in Company
2007年9月3日 - 8:54PM
RNSを含む英国規制内ニュース (英語)
RNS Number:1810D
Alltracel Pharmaceuticals Plc
03 September 2007
Alltracel Pharmaceuticals plc ('Alltracel' or the 'Company')
Holdings in Company
The Company received notification on 3 September, 2007 from Helium Special
Situations Fund that, following its participation in the Company's placing,
announced on 23 August 2007, Helium Special Situations Fund is now interested in
12,250,000 ordinary shares of the Company, representing approximately 8.6 per
cent. of the Company's issued share capital.
The Company received a further notification on 3 September, 2007 from AXA
Framlington that, following its participation in the Company's placing,
announced on 23 August 2007, AXA Framlington is now interested in 13,200,000
ordinary shares of the Company, representing approximately 9.2 per cent. of the
Company's issued share capital.
3 September 2007
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLLJMBTMMAMBTR
Alltracel Pharmaceuticals (LSE:AP.)
過去 株価チャート
から 4 2024 まで 5 2024
Alltracel Pharmaceuticals (LSE:AP.)
過去 株価チャート
から 5 2023 まで 5 2024
Real-Time news about Alltracel PH. (ロンドン証券取引所): 0 recent articles
その他のAlltracel Pharm Plcニュース記事